- RON3.37bn
- RON5.01bn
- RON2.72bn
- 72
- 12
- 96
- 66
Annual income statement for Med Life SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,077 | 1,427 | 1,795 | 2,210 | 2,716 |
Cost of Revenue | |||||
Gross Profit | 887 | 1,087 | 1,274 | 1,612 | 1,990 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 968 | 1,255 | 1,701 | 2,119 | 2,575 |
Operating Profit | 109 | 172 | 94.2 | 91.5 | 140 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 78.6 | 135 | 49.6 | 4.3 | 39.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 63.8 | 113 | 37.4 | -4.16 | 16.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 56.7 | 103 | 32.2 | 3.68 | 25 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 56.7 | 103 | 32.2 | 3.68 | 25 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.101 | 0.194 | 0.058 | 0.013 | 0.053 |
Dividends per Share |